00690.HK
Uni-Bio Science Group Limited
HKSE · Healthcare · Biotechnology · HK
HKD 0.06
+3.45%Margins
Gross margin
82.4%
EBITDA margin
16.7%
EBIT margin
-3.4%
Net margin
12.3%
FCF margin
2.1%
31.2%
Return on equity
23.1%
Return on assets
-7.2%
Return on invested capital
1.92x
Asset turnover
HKD 114.4M
Cash from operations
HKD 0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026